<DOC>
	<DOC>NCT02196818</DOC>
	<brief_summary>This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.</brief_summary>
	<brief_title>A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation, Congenital</mesh_term>
	<criteria>Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery. Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (onlabel use). Patients must be willing to comply with the pre and postoperative evaluation schedule. Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>